Viewing nowCombinationAtovamibe A Tablets 10/10/10 mg (Ezetimibe, Atorvastatin, Amlodipine)
Ezetimibe 10mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation

MFDS item code 202400096 · Approved 2024.01.12
Improvement of dyslipidemia; treatment of hypertension and angina; reduction of the risk of hospitalization and revascularization
This drug is used for patients who require simultaneous administration of amlodipine and the ezetimibe/atorvastatin combination. Amlodipine helps treat hypertension and angina, particularly myocardial ischemia caused by coronary artery vasospasm or constriction. It is also effective in reducing the risk of hospitalization for angina patients and the risks associated with coronary artery revascularization. The ezetimibe/atorvastatin combination helps lower cholesterol and related lipid levels in patients with primary hypercholesterolemia and mixed dyslipidemia, thereby reducing the risk of cardiovascular diseases. It is used as an adjunct to other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia, but its effectiveness for certain types of dyslipidemia has not been studied. In summary, this medication is used to manage hypertension, angina, and both hypercholesterolemia and dyslipidemia together.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of amlodipine and the ezetimibe/atorvastatin combination product. Take the tablet whole; do not chew, split, or crush it. Patients taking amlodipine and the ezetimibe/atorvastatin combination product concomitantly may switch to this drug (a combination product containing the same amount of each active ingredient) for convenience. ○ Amlodipine <Adults> Administer amlodipine orally at a dose of 5mg once daily. The dose may be increased to a maximum of 10 mg daily according to the patient's response. Adjust the dose as appropriate according to age and symptoms. ○ Ezetimibe/atorvastatin combination product Administer this drug once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range of the ezetimibe/atorvastatin combination product is 10/10mg∼10/80mg daily. The recommended initial dose is 10/10mg or 10/20mg daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40mg daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg daily. This drug is used as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful.
This medication carries the risk of rhabdomyolysis, a rare condition where muscle cells are destroyed, potentially leading to kidney problems, due to atorvastatin, one of its active ingredients. Therefore, if acute muscle pain or weakness occurs, consultation with a doctor should be sought immediately, and the drug should be discontinued temporarily if there are risk factors like severe infections or hypotension. This medication should not be used in patients with severe liver impairment, active liver diseases, muscle diseases, pregnant or lactating women. It is also contraindicated in patients with allergies to the active ingredients or components of this drug. Caution should be exercised when administering this drug to patients with a history of alcohol abuse, liver disease, impaired kidney function, hypothyroidism, and elderly patients who are at heightened risk for myopathy. Liver function abnormalities may occur during treatment with this medication, so regular liver function tests should be performed both before and during treatment, and if symptoms of hepatitis or jaundice occur, the medication should be discontinued immediately. This drug can interact with various other medications, so if patients are taking CYP3A4 inhibitors, cyclosporine, HIV protease inhibitors, antibiotics, or some antiviral drugs, they should consult their doctor as dosage adjustments or discontinuation may be necessary. If symptoms like muscle pain, cramps, or weakness occur during treatment, patients should notify their doctor immediately and undergo evaluation, and if severe, the medication should be discontinued. Women of childbearing potential should use appropriate contraception to avoid pregnancy while taking this medication and should not take it if pregnant or potentially pregnant. Additionally, this medication may cause dizziness or drowsiness, necessitating caution when driving or operating machinery.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain its effectiveness and prevents degradation.
Pale yellow film-coated tablets, rectangular
30 tablets/box [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationEzetimibe 10mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Yuhan Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.